Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Cornell Pharmaceutical is a large-scale Chinese pharmaceutical company headquartered in Jilin City, specializing in the research, development, and manufacturing of chemical drugs and formulations. The company focuses on several critical therapeutic areas, including cardiovascular disease, cerebrovascular conditions, and anti-infectives. It operates significant manufacturing facilities that are GMP-certified, producing a variety of delivery formats such as high-volume injections, small-volume injections, and solid oral dosages. As a core member of the Jilin Cornell Group, the company plays a vital role in the domestic Chinese healthcare supply chain. Jilin Cornell is recognized for its industrial scale and its efforts in integrating pharmaceutical production with modern research standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Cornell Pharmaceutical.